YHG-20546-41137
4 vaccinations
9 coded responses
35 check-ins
10 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 750 / TX
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Fatigue, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Fatigue and nausea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-20
-
2021-01-25
Dose 2 — Moderna
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
-
2021-02-08
Survey response — day 14, dose 2MedDRA: Cough, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough and congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-15
Survey response — day 21, dose 2MedDRA: Bronchitis — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: BronchitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-04-26
Survey response — 3 months, dose 2MedDRA: Cough, Respiratory tract congestion, Sneezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sneezing coughing and congestion lasting 14 days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-15
Call successfulDoes not wish to fill out VAERS report
- 2021-07-26
-
2021-11-22
Dose 3 — ModernaCo-administered: Flu
-
2022-01-25
Survey response — 12 months, dose 2MedDRA: Metapneumovirus infection, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infection human meta-PneumovirusMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-28
-
2022-01-28
Call successfulNot applicable - Accidental Reporting
-
2022-02-21
Survey response — 3 months, dose 3MedDRA: Cough, Nasal congestion, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Chest and nasal congestion, cough, runny nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-23
Survey response — 6 months, dose 3MedDRA: Cough, Oropharyngeal pain, Productive cough, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had a sore throat, stuffy head and cough that progressed to congestion in my chest with a productive cough from a non-productive cough at the beginning.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-23
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-19
Dose 4 — Moderna
-
2022-11-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · DiarrheaAdult check-in
-
2022-11-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2022-11-28
- 2022-12-03
-
2022-12-10
Survey response — day 21, dose 4MedDRA: Diarrhoea — Feeling: FairFree text: Loose stool for six days.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Survey response — day 28, dose 4MedDRA: Faeces soft, Frequent bowel movements — Feeling: FairFree text: Continuing soft stool with frequent elimination.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-24
Health check-in — day 35, dose 4Feeling: FairFree text: Joint stiffness, swollen ankles and muscle aches.Adult check-in · check-in free text available
- 2022-12-31
- 2023-02-18
- 2023-05-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-11-22 | Moderna | Flu |
| 4 | 2022-11-19 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 | |
| 2021-02-08 | Successful | Not applicable - Accidental Reporting |
| 2021-02-15 | Successful 2021-07-15 |
Does not wish to fill out VAERS report |
| 2022-01-25 | Successful 2022-01-28 |
Not applicable - Accidental Reporting |
| 2022-05-23 | Successful 2022-05-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 1 — day 14, dose 1
Symptoms: Fatigue and nausea.
Release 3 — day 14, dose 2
Symptoms: Cough and congestion
Release 4 — day 21, dose 2
Symptoms: Bronchitus
Release 8 — 3 months, dose 2
Symptoms: Sneezing coughing and congestion lasting 14 days.
Release 11 — 12 months, dose 2
Symptoms: Upper respiratory infection human meta-Pneumovirus
Release 11 — 3 months, dose 3
Symptoms: Chest and nasal congestion, cough, runny nose.
Release 11 — 6 months, dose 3
Symptoms: I had a sore throat, stuffy head and cough that progressed to congestion in my chest with a productive cough from a non-productive cough at the beginning.
Release 12 — day 21, dose 4
Symptoms: Loose stool for six days.
Release 12 — day 28, dose 4
Symptoms: Continuing soft stool with frequent elimination.
Release 12 — day 35, dose 4
Symptoms: Joint stiffness, swollen ankles and muscle aches.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Faeces soft | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Frequent bowel movements | · | · | ✓ |
| SD | Metapneumovirus infection | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release